Healthcare Global Enterprises Limited has informed the Exchange about Earnings Conference Call that has been scheduled on Wednesday, May 20, 2026, at 01.30 p.m. (IST), to discuss the Audited Financial Results (both Standalone & Consolidated) for the quarter and financial year ended March 31, 2026.
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
HCG (Healthcare Global Enterprises Limited), India's largest cancer care provider, has informed exchanges about an earnings conference call scheduled for May 20, 2026 at 1:30 PM IST. The call will discuss the Audited Financial Results for Q4 and FY26 (quarter and financial year ended March 31, 2026). The Board meeting to approve these results is scheduled for May 19, 2026. Senior management will present the results followed by an interactive Q&A session with investors and analysts. This is a routine regulatory filing under SEBI LODR regulations and follows a prior intimation dated May 01, 2026.
This is a standard procedural announcement informing investors of an upcoming earnings discussion. The actual financial results and management commentary will be released on May 19-20, 2026, which could impact the stock based on performance. No indication of results quality is provided in this intimation.